-
Mashup Score: 6
According to Regeneron, the approval was based on data in the PULSAR and PHOTON trials, in which the drug demonstrated clinically equivalent vision gains to aflibercept Injection 2 mg that were maintained with fewer injections.
Source: www.ophthalmologytimes.comCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0
In a news release, the CDC is urging that clinicians and patients immediately discontinue the use of EzriCare Artificial Tears until the epidemiological investigation and laboratory analyses are complete.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0XEN continues to evolve for use in glaucoma surgery - 1 year(s) ago
Patient-tailored techniques result in predicable outcomes for patients.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0Obesity linked to macular degeneration - 1 year(s) ago
Researchers used obesity as a model to accelerate and exaggerate the stressors experienced by the body throughout life.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 1Patient Case #1: 79-Year-Old Female With Neovascular Age-Related Macular Degeneration (AMD) - 1 year(s) ago
Daniel F Kiernan, MD, FACS, provides an overview of a patient case of a 79-year-old female with neovascular AMD.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 1
According to investigators, the study used curated real-world data from the IRIS Registry to report risk of progression by stage.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0Hundreds of children to receive free eyecare, glasses - 1 year(s) ago
Wills Eye Hospital’s annual Give Kids Sight Day provides access to eyecare for children.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 0Investigators focus on finding cure for AMD - 1 year(s) ago
Scientists from the Clear Vision Research Lab at The Australian National University and the Korean biotech company MDimune Inc. hope to turn recent research milestones into potential treatments for AMD.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 1The pros and cons of local resection of choroidal melanoma - 1 year(s) ago
Spanish investigators found that local resection may offer better visual results and eye sparing without compromising local tumor control and survival.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
-
Mashup Score: 1Ocular biomarkers for cognitive impairment - 1 year(s) ago
The ocular biomarkers studied showed poor to moderate accuracy for detecting the 2 disorders.
Source: Ophthalmology TimesCategories: Latest Headlines, OphthalmologyTweet
BREAKING NEWS: Regeneron Pharmaceuticals announced the FDA has approved aflibercept injection 8 mg for the treatment of patients with wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. #Retina #FDA #OphthTimes https://t.co/3V0NQxc3KB